Evaluation of cytokines and hormones in dogs before and after treatment of diabetic ketoacidosis and in uncomplicated diabetes mellitus
Authors:
- Kenneth DrobatzKDKenneth Drobatz
- Ebenezer SatyarajESEbenezer Satyaraj
- Rebecka HessRHRebecka Hess
- 1 August 2012
- journal article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 148 (3-4) , 276-283
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Diabetic Stem-Cell “Mobilopathy”New England Journal of Medicine, 2011
- Usefulness of Assessing Circulating Levels of Resistin, Ghrelin, and IL-18 in Alcoholic Acute PancreatitisDigestive Diseases and Sciences, 2010
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Prerequisites for cytokine measurements in clinical trials with multiplex immunoassaysBMC Immunology, 2009
- Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 YearsDiabetes Care, 2008
- Acid-base and hormonal abnormalities in dogs with naturally occurring diabetes mellitusJournal of the American Veterinary Medical Association, 2008
- Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humansClinical Immunology, 2005
- Interleukin-18Journal of Leukocyte Biology, 2003
- A mortality prediction model in diabetic ketoacidosisClinical Endocrinology, 2002
- Do multiple outcome measures require p-value adjustment?BMC Medical Research Methodology, 2002